Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The locus control region of the beta-globin gene cluster is a cis-regulatory DNA element found upstream of the beta-globin gene cluster on chromosome 11. It is characterized by a series of DNase I hypersensitive sites and coordinates the developmental-stage- and cell-type-specific transcription of globin genes in erythroid cells. The LCR ensures robust and balanced expression of individual beta-like globin genes (e.g., embryonic, fetal, adult forms) at different developmental stages by orchestrating chromatin loops and recruiting transcription factors[1][4][6]. Disruptions in the LCR can result in reduced or absent globin gene expression and cause disorders such as β-thalassemia. The LCR itself is not a therapeutic target in the classical sense, but its function is pivotal for emerging gene therapies aiming to correct hemoglobinopathies by reactivating fetal globin expression or correcting regulatory defects[1][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Locus control region of the beta-globin gene cluster (LCR (beta-globin)).